Key Events This Week
19 Jan: Stock opens at Rs.423.65, down 2.69%
20 Jan: Hits 52-week low of Rs.415 amid sharp decline
21 Jan: New 52-week low of Rs.399.95 recorded
22 Jan: Sharp rebound with 4.49% gain to Rs.421.15
23 Jan: Modest gain of 0.45% closes week at Rs.423.05
Monday, 19 January 2026: Weak Start Amid Broader Market Decline
Shree Ganesh Remedies Ltd opened the week at Rs.423.65, down 2.69% from the previous close. The stock’s decline was in line with the Sensex, which fell 0.49% to 36,650.97. The volume was relatively low at 3,821 shares, reflecting cautious trading. The weak start foreshadowed the challenging week ahead as the broader market showed signs of stress amid economic uncertainties.
Tuesday, 20 January 2026: Stock Hits 52-Week Low of Rs.415
The stock experienced significant volatility on 20 January, touching a fresh 52-week low of Rs.415. Despite an intraday high of Rs.434.90, the share price closed near the low, down 3.25% at Rs.409.90. This marked a sharp decline amid ongoing financial headwinds. The Sensex also declined sharply by 1.82% to 35,984.65, reflecting a broadly negative market environment. The stock’s fall below all key moving averages underscored sustained bearish momentum.
Just made the cut! This Mid Cap from the Heavy Electrical Equipment sector entered our elite Top 1% list recently. Discover it before the crowd catches on!
- - Top-rated across platform
- - Strong price momentum
- - Near-term growth potential
Wednesday, 21 January 2026: New 52-Week Low at Rs.399.95 Amid Continued Pressure
The downward trend continued on 21 January as the stock hit a new 52-week low of Rs.399.95, closing marginally higher at Rs.403.05 (+0.01%). This represented a 1.67% decline from the previous day’s close. The stock remained below all major moving averages, signalling persistent weakness. The Sensex fell 0.47% to 35,815.26, continuing its three-week losing streak. The company’s financial results and profitability concerns weighed heavily on investor sentiment.
Thursday, 22 January 2026: Sharp Rebound on Lower Volume
On 22 January, Shree Ganesh Remedies Ltd rebounded strongly, gaining 4.49% to close at Rs.421.15. This recovery came on relatively low volume of 1,636 shares, suggesting cautious buying. The Sensex also recovered, rising 0.76% to 36,088.66. The bounce followed the prior days’ steep declines and may reflect short-term technical buying or relief amid oversold conditions.
Friday, 23 January 2026: Modest Gain to Close Week at Rs.423.05
The stock closed the week with a modest gain of 0.45% at Rs.423.05 on 23 January, supported by a volume of 2,844 shares. The Sensex, however, declined 1.33% to 35,609.90, extending its weekly losses. The stock’s relative outperformance versus the benchmark index was limited but notable given the broader market weakness. The company’s Q2 FY26 results released this week highlighted ongoing margin pressures and profitability concerns despite some revenue recovery.
Holding Shree Ganesh Remedies Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Daily Price Comparison: Shree Ganesh Remedies Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-01-19 | Rs.423.65 | -2.69% | 36,650.97 | -0.49% |
| 2026-01-20 | Rs.409.90 | -3.25% | 35,984.65 | -1.82% |
| 2026-01-21 | Rs.403.05 | -1.67% | 35,815.26 | -0.47% |
| 2026-01-22 | Rs.421.15 | +4.49% | 36,088.66 | +0.76% |
| 2026-01-23 | Rs.423.05 | +0.45% | 35,609.90 | -1.33% |
Key Takeaways from the Week
Negative Signals: The stock’s decline to fresh 52-week lows on 20 and 21 January highlights persistent financial and operational challenges. Profitability metrics remain under pressure, with Profit Before Tax down 28.76% year-on-year and Profit After Tax falling 23.96% over six months. The company’s Mojo Score of 26.0 categorises it as a Strong Sell, reflecting deteriorated fundamentals and market sentiment. The absence of domestic mutual fund holdings further signals limited institutional confidence.
Positive Aspects: Despite the week’s losses, Shree Ganesh Remedies Ltd outperformed the Sensex’s sharper decline of 3.31%, falling only 2.83%. The stock’s rebound on 22 January by 4.49% suggests some technical support and potential short-term relief. The company maintains a low Debt to EBITDA ratio of 0.47 times, indicating manageable leverage and financial stability amid earnings challenges. The Price to Book Value ratio near 3.4–3.5 suggests valuation remains reasonable relative to book value.
Conclusion
Shree Ganesh Remedies Ltd’s performance this week reflects a continuation of its challenging trajectory amid financial pressures and subdued market conditions. The stock’s fall to new 52-week lows and weak profitability metrics underscore ongoing headwinds. While the modest outperformance versus the Sensex and the rebound on 22 January offer some respite, the overall outlook remains cautious. Investors will be closely watching upcoming financial disclosures and sector developments to gauge any potential turnaround in the company’s fortunes.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
